Ibersol, S.G.P.S., S.A.

IBS.LS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBS.LS stands at 397.1M. In comparison, EAT.MC has a market cap of 815.6M. Regarding current trading prices, IBS.LS is priced at €9.68, while EAT.MC trades at €3.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBS.LS currently has a P/E ratio of 51.05, whereas EAT.MC's P/E ratio is 94.25. In terms of profitability, IBS.LS's ROE is +0.04%, compared to EAT.MC's ROE of +0.00%. Regarding short-term risk, IBS.LS is less volatile compared to EAT.MC. This indicates potentially lower risk in terms of short-term price fluctuations for IBS.LS.

IBS.LS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBS.LS stands at 397.1M. In comparison, ELIOR.PA has a market cap of 655.9M. Regarding current trading prices, IBS.LS is priced at €9.68, while ELIOR.PA trades at €2.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBS.LS currently has a P/E ratio of 51.05, whereas ELIOR.PA's P/E ratio is 259.20. In terms of profitability, IBS.LS's ROE is +0.04%, compared to ELIOR.PA's ROE of -0.05%. Regarding short-term risk, IBS.LS is less volatile compared to ELIOR.PA. This indicates potentially lower risk in terms of short-term price fluctuations for IBS.LS.

IBS.LS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBS.LS stands at 397.1M. In comparison, ALDBL.PA has a market cap of 5.7M. Regarding current trading prices, IBS.LS is priced at €9.68, while ALDBL.PA trades at €3.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBS.LS currently has a P/E ratio of 51.05, whereas ALDBL.PA's P/E ratio is 3.05. In terms of profitability, IBS.LS's ROE is +0.04%, compared to ALDBL.PA's ROE of +0.49%. Regarding short-term risk, IBS.LS is more volatile compared to ALDBL.PA. This indicates potentially higher risk in terms of short-term price fluctuations for IBS.LS.

IBS.LS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBS.LS stands at 397.1M. In comparison, FLO.PA has a market cap of 0. Regarding current trading prices, IBS.LS is priced at €9.68, while FLO.PA trades at €21.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBS.LS currently has a P/E ratio of 51.05, whereas FLO.PA's P/E ratio is N/A. In terms of profitability, IBS.LS's ROE is +0.04%, compared to FLO.PA's ROE of +1.14%. Regarding short-term risk, IBS.LS is more volatile compared to FLO.PA. This indicates potentially higher risk in terms of short-term price fluctuations for IBS.LS.

IBS.LS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBS.LS stands at 397.1M. In comparison, MLTBM.PA has a market cap of 0. Regarding current trading prices, IBS.LS is priced at €9.68, while MLTBM.PA trades at €3.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBS.LS currently has a P/E ratio of 51.05, whereas MLTBM.PA's P/E ratio is -5.61. In terms of profitability, IBS.LS's ROE is +0.04%, compared to MLTBM.PA's ROE of -1.43%. Regarding short-term risk, IBS.LS is more volatile compared to MLTBM.PA. This indicates potentially higher risk in terms of short-term price fluctuations for IBS.LS.